Dallah Healthcare Co. - stock earnings
4004.SR Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | 113.7 million SAR | 806.0 million SAR |
2023Q3 | 98.9 million SAR | 749.8 million SAR |
2023Q2 | 53.0 million SAR | 670.4 million SAR |
2023Q1 | 94.7 million SAR | 716.6 million SAR |
2022Q4 | 78.4 million SAR | 693.9 million SAR |
2022Q3 | 43.9 million SAR | 600.9 million SAR |
2022Q2 | 69.5 million SAR | 583.8 million SAR |
2022Q1 | 82.6 million SAR | 609.4 million SAR |
2021Q4 | 73.7 million SAR | 575.6 million SAR |
2021Q3 | 84.7 million SAR | 544.1 million SAR |
2021Q2 | 47.5 million SAR | 490.8 million SAR |
2021Q1 | 52.6 million SAR | 494.7 million SAR |
2020Q4 | 17.1 million SAR | 405.3 million SAR |
2020Q3 | 53.8 million SAR | 350.8 million SAR |
2020Q2 | 7.0 million SAR | 247.6 million SAR |
2020Q1 | 19.2 million SAR | 314.6 million SAR |
2019Q4 | 69.8 million SAR | 343.6 million SAR |
2019Q3 | 26.6 million SAR | 301.3 million SAR |
2019Q2 | 15.3 million SAR | 286.0 million SAR |
2019Q1 | 35.2 million SAR | 321.1 million SAR |
2018Q4 | 32.5 million SAR | 318.3 million SAR |
2018Q3 | 32.5 million SAR | 280.9 million SAR |
2018Q2 | 18.7 million SAR | 273.1 million SAR |
2018Q1 | 58.1 million SAR | 308.6 million SAR |
2017Q4 | 63.1 million SAR | 325.9 million SAR |
2017Q3 | 76.8 million SAR | 295.3 million SAR |
2017Q2 | 70.0 million SAR | 288.2 million SAR |
2017Q1 | 85.0 million SAR | 302.8 million SAR |
2016Q4 | 52.0 million SAR | 316.2 million SAR |
2016Q3 | 61.1 million SAR | 273.2 million SAR |
2016Q2 | 54.4 million SAR | 288.3 million SAR |
2016Q1 | 58.3 million SAR | 285.0 million SAR |
2015Q4 | 54.6 million SAR | 275.9 million SAR |
2015Q3 | 26.8 million SAR | 223.9 million SAR |
2015Q2 | 35.9 million SAR | 245.2 million SAR |
2015Q1 | 47.8 million SAR | 240.4 million SAR |
2014Q4 | 50.4 million SAR | 253.3 million SAR |
2014Q3 | 21.9 million SAR | 198.7 million SAR |
2014Q2 | 34.3 million SAR | 227.6 million SAR |
2014Q1 | 40.5 million SAR | 215.4 million SAR |
2013Q4 | 52.1 million SAR | 211.0 million SAR |
2013Q3 | 21.8 million SAR | 167.1 million SAR |
2013Q2 | 23.6 million SAR | 187.8 million SAR |
2013Q1 | 39.0 million SAR | 183.7 million SAR |
2012Q4 | 34.4 million SAR | 178.2 million SAR |
2012Q3 | 23.9 million SAR | 143.7 million SAR |
2012Q2 | 37.1 million SAR | 161.3 million SAR |
2012Q1 | 38.0 million SAR | 154.0 million SAR |
2011Q4 | 35.5 million SAR | 141.9 million SAR |
2011Q3 | 15.5 million SAR | 115.7 million SAR |
4004.SR Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | 360.1 million SAR | 2.9 billion SAR |
2022 | 274.5 million SAR | 2.5 billion SAR |
2021 | 258.6 million SAR | 2.1 billion SAR |
2020 | 97.1 million SAR | 1.3 billion SAR |
2019 | 146.9 million SAR | 1.3 billion SAR |
2018 | 141.8 million SAR | 1.2 billion SAR |
2017 | 295.0 million SAR | 1.2 billion SAR |
2016 | 225.8 million SAR | 1.2 billion SAR |
2015 | 165.1 million SAR | 985.4 million SAR |
2014 | 147.1 million SAR | 895.1 million SAR |
2013 | 136.6 million SAR | 749.7 million SAR |
2012 | 133.4 million SAR | 637.1 million SAR |
2011 | 113.4 million SAR | 527.3 million SAR |
4004.SR
Price: SAR166
Dividend Yield: 0.01%
Forward Dividend Yield: 1.20%
Payout Ratio: 54.05%
Dividend Per Share: 2.00 SAR
Earnings Per Share: 3.70 SAR
P/E Ratio: 49.50
Exchange: SAU
Sector: Healthcare
Industry: Medical Care Facilities
Market Capitalization: 16.2 billion
Average Dividend Frequency: 2
Years Paying Dividends: 12
DGR3: 30.00%
DGR5: 30.00%